Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Yatharth Hospitals Q1 FY25 results

    Yatharth Hospitals Q1 FY25 results: Net profit up 60%, Sales up 37%


    Finance Outlook India Team | Wednesday, 14 August 2024

    Yatharth Hospitals and Trauma Care Services reported a 60% year-on-year (Y-o-Y) increase in consolidated net profit for the June quarter (Q1FY25) to Rs 30.4 crore, up from Rs 19 crore recorded in the same period last year.

    The hospital's operating revenue increased to Rs 211.8 crore in Q1FY25, up 37% year on year from Rs 154.5 crore in Q1FY24. The company's earnings before interest, tax, depreciation, and amortization (EBITDA) increased by 30% year on year to Rs 53.7 crore in the June quarter, with Ebitda margins of 25.3 percent, down from 26.8 percent in Q1FY24.

    According to the company's statement, the margin decline is due to operating losses at Yatharth's recently operationalised Faridabad hospital.On a sequential basis, the company reported a 21% decrease in net profit while sales increased by 19%, from Rs 38.3 crore and Rs 177.8 crore reported in Q4FY24, respectively.

    The company recorded a 9% year-on-year growth in its average revenue per occupied bed (Arpob) at Rs 30,551 in Q1FY25, with bed occupancy climbing to 61% in the June quarter from 51% the previous year. Yatharth Tyagi, whole-time director of Yatharth Hospitals, commented on the company's June quarter statistics, stating that oncology and robotic procedures are significant drivers of Yatharth's increased Arpob and overall occupancy.

    "We continue to professionalize our management and bolster our finance team, with the addition of three key management personnel this quarter, to strengthen our cash flows and balance sheet, and steadfastly pursue our expansion strategy."

    The business intends to increase its bed capacity to 2,800-3,000 beds by FY28, boosting the proportion of super specialties and introducing cancer and robots to drive further Arpob improvement. Tyagi stated that the company's obvious aim is to grow its footprint across North India in order to maintain its leadership and innovation in the healthcare sector.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us